To make this website work, we log user data. By using Shephard's online services, you agree to our Privacy Policy, including cookie policy.

×
Open menu Search

MBDA wraps up Sea Venom qualification firing trials

27th November 2020 - 16:03 GMT | by The Shephard News Team in London

RSS
MBDA has concluded qualification firing trials of the Sea Venom/ANL anti-ship missile.

Weapons manufacturer MBDA announced on 26 November that it has finished qualification firing trials of the Sea Venom/ANL helicopter-launched anti-ship missile. 

The news follows a final successful firing that took place on 17 November at the French MoD test site in Ile du Levant. 

Set to be equipped on both the Royal Navy’s AW159 Wildcat and French Navy's H160M Guepard shipborne helicopters, the Sea Venom/ANL anti-ship missile has been developed as a joint Anglo-French co-operation project under the Lancaster House treaty between Paris and London. 

Briefing detailing the final qualification trial, MBDA said the event tested the 'missile’s advanced target discrimination within a complex and cluttered naval scenario.' 

The Sea Venom will replace the company's AS-15TT and Sea Skua missiles. 

Sea Venom has been designed to allow naval operators to ‘deal with a range of threats including fast-moving patrol boats, corvettes and coastal targets’, according to MBDA company literature, and the missile is capable of dual firing configurations – lock on before and lock on after launch.

The Shephard News Team

Author

The Shephard News Team


As part of our promise to deliver comprehensive coverage to Premium News and Defence Insight …

Read full bio

Share to

Linkedin